On dinner timing, weight management, emerging research, pain, disease prevention, healthcare gaps and more
A recent study as reported by Manjeera Gowravaram examined extracellular vesicles derived from menstrual blood stromal cells and their effects on processes involved in cartilage formation. Another study reported by Anirban Mukhopadhyay takes a closer look at the genetic basis of cerebral palsy . Close on the nutrition and weight-management front is a study from the ICMR-National Institute of Nutrition, which looks at what works better for lasting weight loss. The study finds that combining diet and exercise is more effective for sustained weight loss than either approach alone. The findings are a useful reminder that weight management cannot be reduced to one food, one nutrient or one short-term intervention. From everyday nutrition, we move to some interesting areas of emerging research. Researchers are exploring whether material derived from menstrual blood could have applications in the treatment of osteoarthritis. The findings are from laboratory research and do not establish a treatment for osteoarthritis , but they add to growing interest in regenerative approaches to cartilage damage. Understanding which genetic findings hold up is important not only for research but also for how clinicians interpret genetic information in people with cerebral palsy. On the disease prevention front, rabies remains an important public-health concern. Maya C. reports a study from Keralam that looks at the potential impact of dog vaccination in preventing rabies, underlining the importance of controlling the disease in its animal reservoirs alongside ensuring timely post-exposure care for people. Rabies prevention cannot depend on treating people after exposure alone; sustained vaccination and surveillance of dogs are central to controlling transmission. The issue of counterfeit medicines also highlights why the quality and safety of healthcare products matter. A large stock of suspected counterfeit medicines was seized from a private facility in Bengaluru. Such cases raise concerns that go beyond regulation: a medicine that does not contain what it claims to contain, or does not meet required quality standards, can result in treatment failure and expose patients to further harm.
Researchers found that far fewer genes may have a clear and reproducible association with the condition than some earlier studies had suggested.
